• Poster

Cost-effectiveness of Macugen Compared to Photodynamic Therapy (PDT) with Verteporfin and Standard Care in the Treatment of Subfoveal Wet Age-Related Macular Degeneration (AMD) in the Elderly in Canada

Citation

Earnshaw, S. R., Moride, Y., Moshyk, A., & Rochon, S. (2006, May). Cost-effectiveness of Macugen Compared to Photodynamic Therapy (PDT) with Verteporfin and Standard Care in the Treatment of Subfoveal Wet Age-Related Macular Degeneration (AMD) in the Elderly in Canada. Presented at Third Annual Canadian Joint Therapeutics Congress, .

Abstract